816429-58-0 Usage
General Description
(S,S)-3-Benzyl-1,4-diazabicyclo[4.3.0]nonane is a chemical compound that belongs to the class of heterocyclic compounds. It is a bicyclic compound containing a diazabicyclo[4.3.0]nonane ring system with a benzyl group attached. (S,S)-3-BENZYL-1,4-DIAZABICYCLO[4.3.0]NONANE has the potential to be used in various applications, including as a chiral ligand in asymmetric catalysis and in the synthesis of pharmaceuticals. It has also shown promise in the development of new materials and in the field of medicinal chemistry due to its unique structural features. Additionally, (S,S)-3-Benzyl-1,4-diazabicyclo[4.3.0]nonane has demonstrated biological activity, making it of interest in the development of new drugs and therapeutic agents. Overall, this compound holds potential for a wide range of uses and research applications in the chemical and pharmaceutical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 816429-58-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,6,4,2 and 9 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 816429-58:
(8*8)+(7*1)+(6*6)+(5*4)+(4*2)+(3*9)+(2*5)+(1*8)=180
180 % 10 = 0
So 816429-58-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2/c1-2-5-12(6-3-1)9-13-11-16-8-4-7-14(16)10-15-13/h1-3,5-6,13-15H,4,7-11H2/t13-,14-/m0/s1
816429-58-0Relevant articles and documents
Enantioselective Henry reaction catalyzed by C2-symmetric chiral diamine-copper(II) complex
Selvakumar, Sermadurai,Sivasankaran, Dhanasekaran,Singh, Vinod K.
supporting information; experimental part, p. 3156 - 3162 (2011/02/25)
A copper(II) complex of C2-symmetric diamine has been proved to be an efficient catalyst for the enantioselective Henry reaction between nitroalkanes and various aldehydes to provide β-hydroxy nitroalkanes in high yields (up to 97%), moderate diastereoselectivities (up to 71:29) and excellent enantiomeric excesses (up to 96%). The chiral nitroaldol adduct obtained has been further converted into chiral aziridine in few steps.
